Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-06-11FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRIJARDY XR (empagliflozin, linagliptin, metformin hydrochloride) from Boehringer Ingelheim …
-
FDA approval · 2021-05-17FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Laurus Labs Limited)
FDA approved a supplemental application for Metformin Hydrochloride by Laurus Labs Limited under ANDA 209882; this action updates/expands th…
-
FDA approval · 2021-05-16FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for glipizide submitted by Actavis Pharma, Inc., under an ANDA.
-
FDA approval · 2021-04-30FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approves a supplemental application for OZEMPIC to support the oral semaglutide formulation.
-
FDA approval · 2021-04-30FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for metformin hydrochloride submitted by Zydus Lifesciences Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-04-16FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' original application for Metformin Hydrochloride Extended-Release Tablets, a generic metformin product…
-
FDA approval · 2021-04-12FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for OZEMPIC (semaglutide) from Novo Nordisk, which updates the drug's label and may add a new in…
-
FDA approval · 2021-03-31FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)
FDA approved a supplemental application for Colesevelam hydrochloride from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2021-03-23FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk.
-
FDA approval · 2021-03-09FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approved metformin hydrochloride as an original application generic product from Ajanta Pharma USA Inc.
-
FDA approval · 2021-01-14FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s metformin hydrochloride original application, providing a generic metformin hydrochloride produ…
-
FDA approval · 2020-12-04FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
FDA approval · 2020-12-04FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) from Merck Sharp & Dohme LLC, to the existing NDA for the product.
-
FDA approval · 2020-12-04FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2020-10-30FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRIJARDY XR, a fixed-dose combination tablet of empagliflozin, linagliptin, and metformin hy…
-
FDA approval · 2020-10-13FDA Approved: GLIMEPIRIDE — Supplemental Application (Florida Pharmaceutical Products, LLC)
The FDA approved a supplemental application for a generic version of glimepiride manufactured by Florida Pharmaceutical Products, LLC. No ne…
-
FDA approval · 2020-09-15FDA Approved: GLIMEPIRIDE — Supplemental Application (Micro Labs Limited)
FDA approves a supplemental application for glimepiride from Micro Labs Limited, authorizing a generic version of the diabetes medication.
-
FDA approval · 2020-09-03FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Trulicity (dulaglutide) filed by Eli Lilly and Company.
-
FDA approval · 2020-08-21FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Bromocriptine Mesylate submitted by Padagis US LLC.
-
FDA approval · 2020-08-18FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved Janssen's supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride). This action approves a supplement…
-
FDA approval · 2020-08-18FDA Approved: INVOKAMET XR — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET XR (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals to modify/…
-
FDA approval · 2020-08-18FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKANA (canagliflozin) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2020-08-05FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide. The approval updates the product's labeling/indicati…
-
FDA approval · 2020-07-29FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc., indicating an approv…
-
FDA approval · 2020-06-15FDA Approved: LYUMJEV — Original Application (Eli Lilly and Company)
FDA approves LYUMJEV as an original Biologics License Application from Eli Lilly for glycemic control in people with diabetes mellitus, mark…